SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-024677
Filing Date
2020-11-05
Accepted
2020-11-05 16:15:50
Documents
15
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10016666.htm   iXBRL 8-K 21438
2 EXHIBIT 99.1 brhc10016666_ex99-1.htm EX-99.1 184205
6 image0.jpg GRAPHIC 72450
7 image00001.jpg GRAPHIC 65311
  Complete submission text file 0001140361-20-024677.txt   630635

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cemi-20201105.xsd EX-101.SCH 4192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20201105_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20201105_pre.xml EX-101.PRE 16214
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10016666_htm.xml XML 4061
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 201290643
SIC: 2834 Pharmaceutical Preparations